ProShares Ultra Nasdaq Biotechnology is a n/a business based in the US. ProShares Ultra Nasdaq Biotechnology shares (BIB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $55.10 – an increase of 2.68% over the previous week. ProShares Ultra Nasdaq Biotechnology employs 0 staff and has a trailing 12-month revenue of around .
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $55.10 |
|---|---|
| 52-week range | $42.49 - $69.39 |
| 50-day moving average | $62.83 |
| 200-day moving average | $59.98 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | N/A |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $54.31 from 2024-11-20
| 1 week (2024-11-15) | 1.21% |
|---|---|
| 1 month (2024-10-22) | -14.45% |
| 3 months (2024-08-22) | -17.65% |
| 6 months (2024-05-22) | -7.14% |
| 1 year (2023-11-22) | 24.59% |
|---|---|
| 2 years (2022-11-22) | -8.58% |
| 3 years (2021-11-22) | 83.4416 |
| 5 years (2019-11-22) | 56.2227 |
Dividend payout ratio: % of net profits
Recently ProShares Ultra Nasdaq Biotechnology has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ProShares Ultra Nasdaq Biotechnology shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In ProShares Ultra Nasdaq Biotechnology's case, that would currently equate to about $N/A per share.
ProShares Ultra Nasdaq Biotechnology's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Over the last 12 months, ProShares Ultra Nasdaq Biotechnology's shares have ranged in value from as little as $42.4935 up to $69.3935. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProShares Ultra Nasdaq Biotechnology's is 1.41. This would suggest that ProShares Ultra Nasdaq Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.